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Background: Although few studies have linked cognitive variables with adherence to mammography screening
in women with family histories of breast and/or ovarian cancer, research studies suggest cognitive phenomena
can be powerful adherence predictors.
Methods: This prospective study included 858 women aged 30 to 71 years from the Ontario site of the Breast
Cancer Family Registry with at least one first-degree relative diagnosed with breast and/or ovarian cancer.
Data on beliefs about breast cancer screening and use of mammography were obtained from annual telephone
interviews spanning three consecutive years. Self-reported mammogram dates were confirmed with
medical imaging reports. Associations between beliefs about breast cancer screening and adherence with
annual mammography were estimated using polytomous logistic regression models corrected for familial
correlation. Models compared adherers (N = 329) with late-screeners (N = 382) and never-screeners (N = 147).
Results: Women who believed mammography screening should occur annually were more likely to adhere to
annual screening recommendations than women who believed it should happen less often (OR: 5.02; 95%
CI: 2.97-8.49 for adherers versus late-screeners; OR: 6.82; 95% CI: 3.29-14.16 for adherers versus never-screeners).
Women who believed mammography screening should start at or before age 50 (rather than after)
(OR: 9.72; 95% CI: 3.26-29.02) were significantly more likely to adhere when compared with
never-screeners.
Conclusions: Study results suggest that women with a family history of breast cancer should be strongly
communicated recommendations about initial age of screening and screening intervals as related beliefs
significantly predict adequate adherence.
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Given higher cancer detection rates [1] and increased
odds of diagnosis with smaller, node-negative tumors
with annual screening [2], earlier breast screening initi-
ation (between 30 and 40 years) at shorter intervals
(12 to 18 months) is recommended for women with fam-
ily histories of breast cancers [3,4]. Because of these ap-
parent screening advantages, it can be argued that
screening adherence is especially important for this
population.
Although social cognitive studies reveal beliefs to be
strong adherence predictors across a spectrum of treat-
ments and screening procedures [5-10], very few studies
examined beliefs and screening adherence in women
with familial breast cancer histories. While women with
familial breast cancer histories tend to have better
screening adherence [11-14], no data exists about how
breast cancer screening beliefs can additionally influence
adherence. Instead of beliefs, relevant knowledge has
been emphasized as an adherence predictor, and while
overlaps exist (between knowledge and beliefs), the
knowledge construct operationalized in breast cancer
screening studies does not often include identifications
of specific beliefs. This is unfortunate as knowledge
(alone) has yielded discouraging results in terms of
both information acquisition and retrieval. In a large,
multi-center study of 35 to 50 year old women, nearly
all subjects had insufficient knowledge of screening ef-
fectiveness, although a majority responded correctly to
questions about the purpose/consequences of mam-
mography [15] and African American women (with
and without family histories) had meager knowledge of
several important risk factors (e.g. age, early menarche,
late menopause) although correctly cited family history
as one risk factor [16]. Since an adequate ‘fund’ of
breast cancer-related knowledge appears an elusive goal
in efforts to increase screening rates, focus might be
better placed on promoting retention of a more limited
set of specific beliefs that prove most predictive of
screening adherence. For guidance as to which beliefs
might be emphasized, we reviewed findings indicating
that women who could not recall recommended
screening intervals were significantly less likely to ad-
here [11,13,17,18]. As such our guiding hypothesis was
that the beliefs most predictive of screening adherence
would revolve around screening intervals and age of
initiation. Those two beliefs answer fundamental ques-
tions about when to begin screening and how long to
wait between screening events.
Methods
Study population
A cohort of female relatives of incident cases of invasive
breast cancer was selected from the Ontario site of theBreast Cancer Family Registry (BCFR) funded by the
United States National Cancer Institute. A description of
the BCFR and the Ontario site of the BCFR have been
published [19]. In brief, pathologically confirmed cases
of invasive breast cancer (probands) diagnosed between
1996 and 1998 were identified from the population-
based Ontario Cancer Registry (OCR). Physicians were
contacted to obtain permission to contact their patients
who were mailed a cancer Family History Questionnaire.
Respondents meeting a defined set of family history cri-
teria and a random sample (25%) of those not meeting
the criteria were asked to participate in the Ontario site
of the BCFR. Of those identified at this stage as eligible,
72% (1851/2587) participated.
Probands identified from the OCR were asked for ad-
dress information and permission to contact specific liv-
ing relatives (those affected with breast, ovarian, or
certain other cancers, and their first degree relatives).
An invitation letter to participate in the Ontario site of
the BCFR was sent to relatives. Those agreeing to par-
ticipate were sent an Epidemiology Questionnaire be-
tween 1998 and 2004. Our study was conducted a few
years after the initial recruitment of relatives. For our
study, we identified all female relatives who had: 1) en-
rolled in the Ontario site of the BCFR; 2) completed an
Epidemiology Questionnaire; 3) been unaffected by
breast cancer at the time of the proband’s diagnosis date;
and 4) were alive and between the ages of 30 and
69 years as of January 1st, 2006. Sample size for our
study was limited to the number of female relatives par-
ticipating in the BCFR study, so power calculations were
performed assuming we would have an 80% response
rate from eligible women. From the 3374 participating
female relatives, 2066 (61%) were residents of Ontario
and 1471 (71.2%) of these women met our study inclu-
sion criteria. Women participating provided written
informed consent and this study was approved by the
Research Ethics Boards of Mount Sinai Hospital and the
University Health Network.Data collection
Information was obtained from three questionnaires. Eli-
gible women were sent a baseline Personal History and
Screening Questionnaire between November 2005 and
March 2007. Those who were contacted and agreed to
be interviewed were followed up annually for two years
using the Year 1 and Year 2 Follow-up Personal History
and Screening Questionnaire. An introductory letter and
copy of each questionnaire were sent approximately two
weeks before being contacted by phone. This allowed
time for participants to recall specific dates and events
and allowed referral to the questionnaire during the
interview.
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characteristics, detailed information on breast cancer
screening examinations and women’s beliefs about breast
cancer screening. At each follow-up interview, women
were asked whether they had a mammogram since their
last contact. Women who reported having a mammo-
gram were asked to give either the dates (month and
year) of, or their age at, their last mammogram and the
clinic or hospital where it was performed. In addition,
for women who provided written consent to access their
imaging report, the date and reason for the mammo-
gram were abstracted.
Definitions of breast cancer screening beliefs
Data on beliefs about breast cancer screening were
obtained from questions concerning mammographic fre-
quency (every 6 months; yearly; every two years; every
three years) and initial age for mammographic screening
(less than 30, 30-39; 40-49; 50-59 years). Women were
also asked about the importance (extremely; very; some-
what; not at all) of several risk factors: high fat diet, alco-
hol use, lack of exercise, and family history. Finally,
women rated the likeliness (very likely; somewhat; not
very; not at all) of screening tests (mammogram and
physical breast exam) finding breast cancer.
Definition of annual screening adherence
Information on time-since-last-mammogram and the
reason for mammographic examination obtained from
the imaging report were combined to determine adher-
ence with an annual screening recommendation. A
mammogram was considered a screening mammogram
if the indication on the imaging report was given as rou-
tine or regular screening and non-screening if the mam-
mogram was performed because of a reported symptom
or breast problem. Adherence was defined as returning
within 18 months of a woman’s first reported screening
mammogram which may have been reported in their
baseline or year 1 follow-up interview.
Definition of family history risk
Family history risk of breast and/or ovarian cancer was
based on information collected from the Family History
Questionnaire completed by the relative’s proband using
a modified definition of previously referenced groups for
familial breast cancer risk [3,20]. Women were consid-
ered to have a low familial risk if they had only one first-
degree relative diagnosed with breast cancer after the
age of 40. Women were considered to have a moderate
familial risk if they had: 1) a self-reported Ashkenazi
Jewish background; and/or 2) one first-degree relative
with breast cancer diagnosed before the age of 40; or 3)
one first-degree relative with ovarian cancer; or 4) one
first-degree relative with breast cancer diagnosed afterthe age of 40 and two or more second-degree relatives
with breast cancer diagnosed at any age. Finally, women
were considered to have a high familial risk if they had:
1) two or more first-degree relatives with breast and/or
ovarian cancer diagnosed at any age; and/or 2) one or
more first-degree relative(s) with both breast and ovarian
cancer diagnosed at any age; and/or 3) one or more
first-degree relative(s) diagnosed with bilateral breast
cancer at any age; and/or 4) a personal history of ovarian
cancer.
Definition of demographic and health characteristics
Demographic questions included date of birth from
which age at interview was calculated (under 50 years;
50 years or older), highest level of education achieved
(high school or less; some college/university/vocational/
technical; bachelor’s degree or higher) and current mari-
tal status (married or common law; single, widowed,
divorced, or separated). Information on health practices
included a question on the number of yearly visits to
health professionals on average in the last two years
(once a year or less; 2 to 3 times per year; 4 or more
times per year).
Statistical analyses
Polytomous logistic regression analyses were used to
examine associations between demographic characteris-
tics, health practices, familial risk, breast cancer screen-
ing beliefs and adherence with annual screening within
18 months of the first reported mammogram, adjusted
for age at baseline interview. Breast cancer screening be-
lief questions were also adjusted by education, visits to
health professionals and family history risk. Adherers
were compared to late-screeners and never-screeners in
each model. Models including interactions between each
belief question and age or familial risk were examined to
assess whether they were potential effect modifiers for
breast cancer screening and beliefs. As no interaction
was evident, no stratified analyses were performed. Since
many study participants were members of the same fam-
ily and could have similar cancer screening behaviors, a
robust variance estimate was used to adjust for potential
correlation due to family clustering [21,22]. Adjusted
odds ratios (OR) and 95% confidence intervals (CI) were
calculated. All ‘don’t know’ responses and refusals were
excluded from the analyses. Analyses were conducted
using SAS [23] and all reported P values are for two-
sided alternatives with values <0.05 considered
significant.
Results
Of the 1471 eligible women sent a baseline Personal His-
tory and Screening Questionnaire, 1309 (89.0%) were
contacted, 1071 (81.8%) agreed to participate and 69
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nosis and n = 32 did not have a first-degree relative with
breast and/or ovarian cancer). Of the 1002 women sent
a Year 1 Follow-up Personal History and Screening Ques-
tionnaire, 942 (94.0%) were interviewed. Of the 936
women without breast cancer sent a Year 2 Follow-up
Personal History and Screening Questionnaire, 856
(91.5%) were interviewed. Women who reported having
a mammogram (817 at baseline, 558 at year 1 and 540 at
year 2) were asked to provide written consent for access
to their medical imaging report. In total, 776 (95.0%),
536 (96.0%) and 511 (94.6%) consented to share their
mammogram report after completing the baseline, year
1 and year 2 questionnaires, respectively; and of these,
774 (99.7%), 453 (84.6%) and 497 (97.3%) reports were
received.
Of the 646 eligible women with a baseline screening
mammogram (Figure 1), 420 reported a screening mam-
mogram at year 1 (291 within 18 months and 129 be-
yond 18 months). Of the remaining 226 women with no
screening mammogram at year one, 99 reported a
screening mammogram at their second year interview (9
within 18 months and 90 beyond 18 months) and 127
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Figure 1 Tree diagram of women included in the study..baseline screening mammogram but screening mammo-
grams at year 1 and 2, 29 of which returned within
18 months and 36 beyond 18 months. Overall, 711
women reported at least two screening mammograms,
of which 329 (46.3%) were adherers and 382 (53.7%)
were late-screeners. There were 147 women who
reported having no mammogram at all three interviews
(baseline, year 1 and year 2) and these women were con-
sidered never-screeners.
The final sample size included 858 women from 569
unique families of which 381 (67.0%) had one family
member, 121 (21.3%) had two family members and 67
(11.7%) had three to seven family members. The major-
ity of adherers and late-screeners were aged 50 years or
older (74.1% and 57.1%, respectively) whereas the major-
ity of never-screeners were under age 50 (87.8%)
(Table 1). For adherers, a similar distribution was found
of women in the low, moderate and high familial risk
groups, whereas, nearly 50% of the late-screeners and
more than 70% of the never-screeners were at low famil-
ial risk. Moderate (OR: 1.55; 95% CI: 1.06-2.27) or high
(OR: 1.48; 95% CI: 1.04-2.12) versus low familial risk was
significantly associated with a woman returning for

































7 Lost to follow-up 20 Lost to follow-up
Table 1 Adjusted odds ratios (ORs) with 95% confidence intervals (CI) for adherence to annual breast screening by
demographic, family history risk and visits to health professionals for female relatives from the Ontario site of the
Breast Cancer Family Registry













Age at baseline interview (years)
30-39 11 (3.4) 30 (7.8) 97 (66.0)
40-49 74 (22.5) 134 (35.1) 32 (21.8)
50-59 133 (40.4) 136 (35.6) 12 (8.1)
≥ 60 111 (33.7) 82 (21.5) 6 (4.1)
Family History Risk
Low 124 (37.7) 189 (49.5) 103 (70.1) 1.00 1.00
Moderate 92 (28.0) 89 (23.3) 24 (16.3) 1.55 (1.06, 2.27)† 2.47 (1.38, 4.41){
High 113 (34.3) 104 (27.2) 20 (13.6) 1.48 (1.04, 2.12)δ 2.01 (1.06, 3.80)δ
Education level
High school or less 122 (37.1) 115 (30.2) 22 (14.9) 1.00 1.00
Some college/university/
vocational/technical school 124 (37.7) 166 (43.6) 57 (38.8) 0.86 (0.60, 1.24) 1.38 (0.69, 2.76)
Bachelor’s degree or higher 83 (25.2) 100 (26.2) 68 (46.3) 1.02 (0.68, 1.54) 1.08 (0.55, 2.12)
Married or Common-Law
Yes 272 (82.7) 314 (82.2) 126 (85.7) 1.00 1.00
No 57 (17.3) 68 (17.8) 21 (14.3) 0.90 (0.60, 1.35) 1.32 (0.66, 2.66)
Visits to Health Professionals
Once a year or less 109 (33.1) 134 (35.1) 55 (37.4) 1.00 1.00
2-3 times per year 148 (45.0) 142 (37.2) 61 (41.5) 1.25 (0.88, 1.77) 1.23 (0.73, 2.08)
4 or more times per year 72 (21.9) 106 (27.7) 31 (21.1) 0.76 (0.51, 1.14) 1.21 (0.67, 2.20)
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high (OR: 2.01; 95% CI: 1. 06-3.80) versus low familial
risk were significantly associated with women returning
within 18 months versus never being screened. A major-
ity of the women had more than a high school educa-
tion, were married and had visited a health professional
three times or less per year in all three screening groups.
Women who indicated a belief in annual mammogram
screening were significantly more likely to be screening
adherent (OR: 5.02; 95% CI: 2.97-8.49 for adherers ver-
sus late-screeners and OR: 6.82; 95% CI: 3.29-14.16 for
adherers versus never-screeners) than women who
believed in a lesser frequency (Table 2). When adherers
were compared with never-screeners, women who
believed mammography should start for higher risk
women before age 50 were significantly more likely to
adhere than those who thought it should start
at ≥ 50 years (OR: 9.72; 95% CI: 3.26-29.02). Screening
adherence was not associated with beliefs about breast
cancer risk factors or beliefs about the likeliness of amammogram finding breast cancer when adherers were
compared with late-screeners or never-screeners.
Discussion
This study found specific beliefs about breast screening
associated with screening adherence. Women who
believed in annual screening were nearly five times more
likely to adhere to screening (within 18 months) than
women who believed they should return less often. Sub-
jects who believed they should start screening before
50 years of age (rather than afterwards) were nearly 10
times more likely to adhere than those who were never-
screened.
Studies of average risk women between 50-69 years par-
ticipating in screening programs and two broader popula-
tion surveys including women 40-75 years have shown
that a high proportion believe in the appropriate fre-
quency of screening. Between 77.2% and 94.1% reported
beliefs that women should be screened every 1-2 years
[11,13,18,24]. These data become more consequential
Table 2 Adjusted odds ratios (ORs) with 95% confidence intervals (CI) for adherence to annual breast screening by
breast screening belief factors for female relatives from the Ontario site of the Breast Cancer Family Registry














Less often (once every
two years or more) 23 (7.0) 97 (26.6) 39 (30.0) 1.00 1.00
At least once per year 306 (93.0) 267 (73.4) 91 (70.0) 5.02 (2.97, 8.49)† 6.82 (3.29, 14.16)†
Age start screening mammogram
≥50 26 (8.1) 28 (7.6) 11 (7.7) 1.00 1.00
<50 296 (91.9) 341 (92.4) 132 (92.3) 1.38 (0.75, 2.55) 9.72 (3.26, 29.02)†
Importance of Breast Cancer Risk Factors
High fat diet
Not at all/Somewhat important 101 (37.5) 144 (44.7) 58 (44.3) 1.00 1.00
Very/Extremely important 168 (62.5) 178 (55.3) 73 (55.7) 1.22 (0.87, 1.70) 1.23 (0.74, 2.06)
Alcohol use
Not at all/Somewhat important 172 (63.9) 221 (68.6) 93 (71.0) 1.00 1.00
Very/Extremely important 97 (36.1) 101 (31.4) 38 (29.0) 1.17 (0.82, 1.67) 1.20 (0.69, 2.07)
Lack of exercise
Not at all/Somewhat important 105 (39.1) 147 (45.7) 58 (44.3) 1.00 1.00
Very/Extremely important 164 (60.9) 175 (54.3) 73 (55.7) 1.21 (0.87, 1.68) 1.50 (0.89, 2.52)
Family history of breast cancer
Not at all/Somewhat important 22 (8.2) 22 (6.8) 10 (7.6) 1.00 1.00
Very/Extremely important 247 (91.8) 300 (93.2) 121 (92.4) 0.90 (0.47, 1.71) 1.32 (0.45, 3.87)
Likeliness mammogram finding
breast cancer
Not at all/not very likely 122 (37.1) 150 (39.8) 55 (37.9) 1.00 1.00
Very/somewhat likely 207 (62.9) 227 (60.2) 90 (62.1) 1.10 (0.79, 1.53) 1.24 (0.75, 2.05)
*Adjusted by age at interview, education, visits to health professionals, family risk and were corrected for familial clustering.
†p-value =<0.0001.
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predict screening adherence in women with a family
history of breast cancer. Our findings are consistent
with studies that examined this relationship in average
risk women over age 50 where women who reported
screening should occur every 1-2 years (in the US and
Australia where biennial mammography screening is
recommended) were significantly more likely to adhere
than women who reported mammograms should occur
less often [17,18].
The same association between beliefs regarding
screening timeliness and adherence was supported in a
previous study of average-risk women, 50-75 years,
attending the Ontario Breast Screening Program. We
found those who believed in less frequent than biennial
screening were significantly less likely to biennially
screen [24]. These findings underscore the importance
of communicating a screening interval recommendation
to women at increased risk for breast cancer withsufficient strength that they develop strong beliefs about
the need to screen at the specific interval recommended.
We found no significant association between women
believing a mammogram was likely to find breast cancer
and screening adherence. This contrasts with previous
research that found women who believe mammograms
are effective are more likely to adhere [11,14]. One rea-
son for the inconsistency may be that our subjects were
high risk women compared to the other studies that
included average risk women.
Previous research in average risk women has shown
that referring physicians have an important influence on
women, in terms of both initially attending screening
and subsequent screening adherence [12,13,25-28]. A re-
cent Australian study of women with a strong family his-
tory of breast cancer confirms this as women who
attended mammography screening less often than
recommended in national guidelines were less likely to
have received a screening recommendation compared to
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professionals should be encouraged to not only discuss
screening benefits but to strongly emphasize screening
timeliness, particularly to those at high risk, because our
findings suggest cognitions relating to screening inter-
vals may be key in actual (timely) screening adherence.
To our knowledge, this is the first study to examine
the impact of beliefs about breast cancer screening on
screening adherence in women at high familial risk. Be-
cause our study includes a large cohort of female rela-
tives of population-based breast cancer cases, there was
sufficient power to examine associations and minimize
self-referral bias. An additionally important strength is
our prospective examination of the impact of beliefs on
adherence. Finally, we obtained actual mammography
dates to calculate adherence rather than relying on self-
reported data. While self-reported mammography data
has been found to be accurate for determining whether
a woman has had a mammogram, it is less accurate in
determining the interval since last mammogram [30].
Our study limitations include being unable to deter-
mine adherence or non-adherence in approximately
7.0% of women who did not provide consent to access
their mammogram report and in 7.4% of women who
were lost to follow-up. In addition, self-reported data
was used for determining family history of breast cancer.
Previous research has demonstrated that patient-
reported family cancer histories for first-degree relatives
are accurate for breast cancer risk assessments, although
accuracy is somewhat lower for second-degree relatives
[31]. Finally, our study findings may have limited
generalizability as participants were family members of
breast cancer cases identified from a population-based
registry in Ontario, Canada where universal health care
coverage (covering all physician referred screening at
any age) and an organized breast cancer screening pro-
gram for women 50 to 74 years of age are available.
Conclusions
Altogether, this study found that believing in the appro-
priate frequency and age range to begin breast screening
was associated with significantly increased adherence to
annual screening for women at familial risk. In contrast,
beliefs about the importance of risk factors for breast
cancer were not associated with adherence. Study results
suggest women with a family history of breast cancer
should continue to be informed about breast cancer
screening benefits, but special emphasis should be
placed on strongly communicating the recommended
frequency and age to begin screening for women at
increased familial risk. If women develop strong beliefs
about optimal frequency and age to begin screening, our
study indicates their breast screening adherence will be
significantly improved.Abbreviations
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